CLINICAL_TRIALS
trial_result
· 2024-01-05
Clinical Trial Update: Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation [Phase 4]
Summary
Phase 4 trial updating post-lesion dexamethasone to prevent neuritis after radiofrequency ablation was terminated; results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Neuritis, Radiofrequency Ablation | Phase 4 | Status: TERMINATED | Results posted: 2024-01-05